PubMed for id: 5602

Year	Number of Results
1991	1
1994	1
1995	1
1996	2
1997	5
1998	3
1999	4
2000	6
2001	10
2002	8
2003	8
2004	7
2005	5
2006	6
2007	2
2008	3
2009	7
2010	4
2011	9
2012	4
2013	2
2014	10
2015	4
2016	2
2017	2
2018	2
2019	4
2020	7
2021	4
2024	0

1

Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes.

Tsai YC, Huang CY, Hsueh YM, Fan YC, Fong YC, Huang SP, Geng JH, Chen LC, Lu TL, Bao BY. Tsai YC, et al. Life Sci. 2021 Jun 15;275:119396. doi: 10.1016/j.lfs.2021.119396. Epub 2021 Mar 24. Life Sci. 2021. PMID: 33774030

2

JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases.

Musi CA, Agrò G, Santarella F, Iervasi E, Borsello T. Musi CA, et al. Cells. 2020 Sep 28;9(10):2190. doi: 10.3390/cells9102190. Cells. 2020. PMID: 32998477 Free PMC article. Review.

3

Circ_0000515 drives the progression of hepatocellular carcinoma by regulating MAPK10.

Li H, Li CM, Yuan R, Wang HB, Wei J. Li H, et al. Eur Rev Med Pharmacol Sci. 2020 Jun;24(11):6014-6022. doi: 10.26355/eurrev_202006_21495. Eur Rev Med Pharmacol Sci. 2020. PMID: 32572915 Free article.

4

Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay.

Rajan RK, Ramanathan M. Rajan RK, et al. J Comput Aided Mol Des. 2020 Jun;34(6):671-682. doi: 10.1007/s10822-020-00297-y. Epub 2020 Feb 10. J Comput Aided Mol Des. 2020. PMID: 32040807

5

Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10.

Li L, Luo Z. Li L, et al. Oncol Rep. 2017 May;37(5):2679-2687. doi: 10.3892/or.2017.5544. Epub 2017 Mar 31. Oncol Rep. 2017. PMID: 28393229 Free PMC article.

6

Peptide mini-scaffold facilitates JNK3 activation in cells.

Zhan X, Stoy H, Kaoud TS, Perry NA, Chen Q, Perez A, Els-Heindl S, Slagis JV, Iverson TM, Beck-Sickinger AG, Gurevich EV, Dalby KN, Gurevich VV. Zhan X, et al. Sci Rep. 2016 Feb 12;6:21025. doi: 10.1038/srep21025. Sci Rep. 2016. PMID: 26868142 Free PMC article.

7

Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline.

Gourmaud S, Paquet C, Dumurgier J, Pace C, Bouras C, Gray F, Laplanche JL, Meurs EF, Mouton-Liger F, Hugon J. Gourmaud S, et al. J Psychiatry Neurosci. 2015 May;40(3):151-61. doi: 10.1503/jpn.140062. J Psychiatry Neurosci. 2015. PMID: 25455349 Free PMC article.

8

Phosphorylation- and nucleotide-binding-induced changes to the stability and hydrogen exchange patterns of JNK1β1 provide insight into its mechanisms of activation.

Owen GR, Stoychev S, Achilonu I, Dirr HW. Owen GR, et al. J Mol Biol. 2014 Oct 23;426(21):3569-89. doi: 10.1016/j.jmb.2014.08.019. Epub 2014 Aug 29. J Mol Biol. 2014. PMID: 25178256

9

JNK3 is required for the cytoprotective effect of exendin 4.

Ezanno H, Pawlowski V, Abdelli S, Boutry R, Gmyr V, Kerr-Conte J, Bonny C, Pattou F, Abderrahmani A. Ezanno H, et al. J Diabetes Res. 2014;2014:814854. doi: 10.1155/2014/814854. Epub 2014 Jun 16. J Diabetes Res. 2014. PMID: 25025079 Free PMC article.

10

Characterisation of de novo MAPK10/JNK3 truncation mutations associated with cognitive disorders in two unrelated patients.

Kunde SA, Rademacher N, Tzschach A, Wiedersberg E, Ullmann R, Kalscheuer VM, Shoichet SA. Kunde SA, et al. Hum Genet. 2013 Apr;132(4):461-71. doi: 10.1007/s00439-012-1260-5. Epub 2013 Jan 18. Hum Genet. 2013. PMID: 23329067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year